AAAAAA
Results:
1-18
|
Results: 18
Authors:
BOOKMAN MA
Citation: Ma. Bookman, SALVAGE THERAPY FOR OVARIAN-CANCER, Oncology, 12(6), 1998, pp. 844
Authors:
BOOKMAN MA
MALMSTROM H
BOLIS G
GORDON A
LISSONI A
KREBS JB
FIELDS SZ
Citation: Ma. Bookman et al., TOPOTECAN FOR THE TREATMENT OF ADVANCED EPITHELIAL OVARIAN-CANCER - AN OPEN-LABEL PHASE-II STUDY IN PATIENTS TREATED AFTER PRIOR CHEMOTHERAPY THAT CONTAINED CISPLATIN OR CARBOPLATIN AND PACLITAXEL, Journal of clinical oncology, 16(10), 1998, pp. 3345-3352
Authors:
BOOKMAN MA
Citation: Ma. Bookman, BIOLOGICAL THERAPY OF OVARIAN-CANCER - CURRENT DIRECTIONS, Seminars in oncology, 25(3), 1998, pp. 381-396
Authors:
BOOKMAN MA
KLOTH DD
KOVER PE
SMOLINSKI S
OZOLS RF
Citation: Ma. Bookman et al., SHORT-COURSE INTRAVENOUS PROPHYLAXIS FOR PACLITAXEL-RELATED HYPERSENSITIVITY REACTIONS, Annals of oncology, 8(6), 1997, pp. 611-614
Authors:
OREILLY S
FLEMING GF
BAKER SD
WALCZAK JR
BOOKMAN MA
MCGUIRE WP
SCHILDER RJ
ALVAREZ RD
ARMSTRONG DK
HOROWITZ IR
OZOLS RF
ROWINSKY EK
Citation: S. Oreilly et al., PHASE-I TRIAL AND PHARMACOLOGICAL TRIAL OF SEQUENCES OF PACLITAXEL AND TOPOTECAN IN PREVIOUSLY TREATED OVARIAN EPITHELIAL MALIGNANCIES - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(1), 1997, pp. 177-186
Authors:
BOOKMAN MA
KLOTH DD
KOVER PE
SMOLINSKI S
OZOLS RF
Citation: Ma. Bookman et al., INTRAVENOUS PROPHYLAXIS FOR PACLITAXEL-RELATED HYPERSENSITIVITY REACTIONS, Seminars in oncology, 24(6), 1997, pp. 13-15
Authors:
BOOKMAN MA
OZOLS RF
Citation: Ma. Bookman et Rf. Ozols, FACTORING OUTCOMES IN OVARIAN-CANCER, Journal of clinical oncology, 14(2), 1996, pp. 325-327
Authors:
ODWYER PJ
HAMILTON TC
LACRETA FP
GALLO JM
KILPATRICK D
HALBHERR T
BRENNAN J
BOOKMAN MA
HOFFMAN J
YOUNG RC
COMIS RL
OZOLS RF
Citation: Pj. Odwyer et al., PHASE-I TRIAL OF BUTHIONINE SULFOXIMINE IN COMBINATION WITH MELPHALANIN PATIENTS WITH CANCER, Journal of clinical oncology, 14(1), 1996, pp. 249-256
Authors:
LOOK KY
BLESSING JA
ADELSON MD
MORRIS M
BOOKMAN MA
Citation: Ky. Look et al., A PHASE-II TRIAL OF MERBARONE (NSC-336628) IN THE TREATMENT OF RECURRENT EPITHELIAL OVARIAN-CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 19(1), 1996, pp. 7-9
Authors:
ADAMS GP
MCCARTNEY JE
WOLF EJ
EISENBERG J
TAI MS
HUSTON JS
STAFFORD WF
BOOKMAN MA
HOUSTON LL
WEINER LM
Citation: Gp. Adams et al., OPTIMIZATION OF IN-VIVO TUMOR TARGETING IN SCID MICE WITH DIVALENT FORMS OF 741F8 ANTI-C-ERBB-2 SINGLE-CHAIN FV - EFFECTS OF DOSE-ESCALATION AND REPEATED IV ADMINISTRATION, Cancer immunology and immunotherapy, 40(5), 1995, pp. 299-306
Authors:
MCCARTNEY JE
TAI MS
HUDZIAK RM
ADAMS GP
WEINER LM
JIN D
STAFFORD WF
LIU S
BOOKMAN MA
LAMINET AA
FAND I
HOUSTON LL
OPPERMANN H
HUSTON JS
Citation: Je. Mccartney et al., ENGINEERING DISULFIDE-LINKED SINGLE-CHAIN FV DIMERS [(SFV')(2)] WITH IMPROVED SOLUTION AND TARGETING PROPERTIES - ANTIDIGOXIN-26-10 (SFV')(2) AND ANTI-C-ERBB-2 741F8 (SFV')(2) MADE BY PROTEIN-FOLDING AND BONDED THROUGH C-TERMINAL CYSTEINYL PEPTIDES, Protein engineering, 8(3), 1995, pp. 301-314
Authors:
ADAMS GP
MCCARTNEY JE
WOLF EJ
EISENBERG J
HUSTON JS
BOOKMAN MA
MOLDOFSKY P
STAFFORD WF
HOUSTON LL
WEINER LM
Citation: Gp. Adams et al., ENHANCED TUMOR SPECIFICITY OF 741F8-1(SFV')(2), AN ANTI-C-ERBB-2 SINGLE-CHAIN FV DIMER, MEDIATED BY STABLE RADIOIODINE CONJUGATION, The Journal of nuclear medicine, 36(12), 1995, pp. 2276-2281
Authors:
TAI MS
MCCARTNEY JE
ADAMS GP
JIN D
HUDZIAK RM
OPPERMANN H
LAMINET AA
BOOKMAN MA
WOLF EJ
LIU S
STAFFORD WF
FAND I
HOUSTON LL
WEINER LM
HUSTON JS
Citation: Ms. Tai et al., TARGETING C-ERBB-2 EXPRESSING TUMORS USING SINGLE-CHAIN FV MONOMERS AND DIMERS, Cancer research, 55(23), 1995, pp. 5983-5989
Authors:
MOUTSCHEN MP
SHAN H
GIANTONIO BJ
BOOKMAN MA
Citation: Mp. Moutschen et al., PRECURSOR CTL SPECIFIC FOR RETROVIRUS-INDUCED T-LYMPHOMA ARE FOUND ATHIGH-FREQUENCY IN UNPRIMED SYNGENEIC MICE, Cellular immunology, 153(2), 1994, pp. 367-377
Authors:
REED E
JANIK J
BOOKMAN MA
ROTHENBERG M
SMITH J
YOUNG RC
OZOLS RF
VANDERMOLEN L
KOHN E
JACOB JL
CORNELISON TL
Citation: E. Reed et al., HIGH-DOSE CARBOPLATIN AND RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN ADVANCED-STAGE RECURRENT OVARIAN-CANCER, Journal of clinical oncology, 11(11), 1993, pp. 2118-2126
Authors:
BOOKMAN MA
Citation: Ma. Bookman, BIOLOGIC THERAPY IN THE MANAGEMENT OF REFRACTORY OVARIAN-CANCER, Gynecologic oncology, 51(1), 1993, pp. 113-126
Authors:
ADAMS GP
HUSTON JS
HOUSTON LL
FAND I
BOOKMAN MA
WEINER LM
Citation: Gp. Adams et al., INVIVO TUMOR SPECIFICITY OF MONOMERIC AND DIMERIC FORMS OF THE 25 KD ANTI-C-ERBB-2 SINGLE-CHAIN FV (SFV) MOLECULE, 741F8, The Journal of immunology, 150(8), 1993, pp. 142-142
Authors:
ADAMS GP
MCCARTNEY JE
TAI MS
OPPERMANN H
HUSTON JS
STAFFORD WF
BOOKMAN MA
FAND I
HOUSTON LL
WEINER LM
Citation: Gp. Adams et al., HIGHLY SPECIFIC IN-VIVO TUMOR TARGETING BY MONOVALENT AND DIVALENT FORMS OF 741F8 ANTI-C-ERBB-2 SINGLE-CHAIN FV, Cancer research, 53(17), 1993, pp. 4026-4034
Risultati:
1-18
|